1. Mammalian animal models for dengue virus infection: a recent overview
- Author
-
Kyoko Tsukiyama-Kohara and Mohammad Enamul Hoque Kayesh
- Subjects
medicine.medical_specialty ,Dengue hemorrhagic fever ,viruses ,Review ,Dengue virus ,Biology ,Dengue shock syndrome ,medicine.disease_cause ,Dengue fever ,Dengue ,Pathogenesis ,Tree shrew ,Mice ,Medical microbiology ,Virology ,Vaccine Development ,medicine ,Animals ,virus diseases ,General Medicine ,biochemical phenomena, metabolism, and nutrition ,Dengue Virus ,medicine.disease ,Disease Models, Animal ,Viral disease - Abstract
Dengue, a rapidly spreading mosquito-borne human viral disease caused by dengue virus (DENV), is a public health concern in tropical and subtropical areas due to its expanding geographical range. DENV can cause a wide spectrum of illnesses in humans, ranging from asymptomatic infection or mild dengue fever (DF) to life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Dengue is caused by four DENV serotypes; however, dengue pathogenesis is complex and poorly understood. Establishing a useful animal model that can exhibit dengue-fever-like signs similar to those in humans is essential to improve our understanding of the host response and pathogenesis of DENV. Although several animal models, including mouse models, non-human primate models, and a recently reported tree shrew model, have been investigated for DENV infection, animal models with clinical signs that are similar to those of DF in humans have not yet been established. Although animal models are essential for understanding the pathogenesis of DENV infection and for drug and vaccine development, each animal model has its own strengths and limitations. Therefore, in this review, we provide a recent overview of animal models for DENV infection and pathogenesis, focusing on studies of the antibody-dependent enhancement (ADE) effect in animal models.
- Published
- 2021
- Full Text
- View/download PDF